Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $530

Benzinga · 14h ago
Scotiabank analyst Louise Chen maintains Amgen (NASDAQ:AMGN) with a Sector Outperform and raises the price target from $500 to $530.